Neb Obradovic
@Cormorant Asset Management, Lp
Latest period2024 - Q3ReportedManaged Assets$1.886BTotal holdings45
Assets growth rate8.94%Assets growth rate (2-Q avg)-7.56%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.
Assets under management
The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.886B in assets, with a quarterly growth rate of 8.94% and a 2-quarter average growth rate of -7.56%. The portfolio is managed by Neb Obradovic, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SRPTSarepta Therapeutics Inc
| 0% | $19.75M 125,000 shares@ $158.0 avg price | Exited |
CGEMCullinan Therapeutics Inc
| 0% | $19.62M 1.125M shares@ $17.44 avg price | Exited |
IDYAIdeaya Biosciences Inc
| 0% | $8.602M 245,000 shares@ $35.11 avg price | Exited |
IBRXImmunitybio Inc
| 0% | $7.9M↓ Put 1.25M shares@ $6.32 avg price | Exited |
LNTHLantheus Hldgs Inc
| 0% | $6.022M 75,000 shares@ $80.29 avg price | Exited |
MRSNMersana Therapeutics Inc
| 0% | $5.226M 2.6M shares@ $2.01 avg price | Exited |
SIGASiga Technologies Inc
| 0% | $3.795M↓ Put 500,000 shares@ $7.59 avg price | Exited |
CMPXCompass Therapeutics Inc
| 0% | $2.031M 2.031M shares@ $1.0 avg price | Exited |